SCHEMBL5791679

SCHEMBL5791679

CC(O)(CC(N)OCc1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 2/20 0.39
IDO1 P14902 2/20 0.38
KIF11 P52732 1/20 0.37
KMT2A Q03164 3/20 0.36
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
MEN1 O00255 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPK1 P28482 1/20 0.35
SLC6A4 P31645 1/20 0.34
SLC6A3 Q01959 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
TP53 P04637 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792856 0.90 SLC1A3 (0.44) IDO1KIF11KMT2ASLC1A3SLC1A2
SCHEMBL5794403 0.88 TACR1 (0.43) IDO1KMT2ASLC1A3SLC1A2SLC1A1
SCHEMBL5793858 0.86 CHRNB2 (0.47) CHRM3IDO1KIF11KMT2AMEN1
SCHEMBL5790287 0.86 SLC6A4 (0.44) CHRM3IDO1KIF11KMT2ASLC1A3
SCHEMBL5793923 0.85 IDO1 (0.44) CHRM3IDO1CYP2C19
SCHEMBL5791685 0.85 IDO1 (0.44) IDO1KIF11KMT2ASLC1A3SLC1A2
SCHEMBL5794077 0.81 TACR1 (0.47) TACR1
SCHEMBL5793829 0.81 IDO1 (0.42) CHRM3IDO1KIF11KMT2ACYP2C19
SCHEMBL5791672 0.80 TACR1 (0.46) IDO1KIF11KMT2ALMNAKDM4E
SCHEMBL5790274 0.78 IDO1 (0.45) CHRM3IDO1KIF11CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006014942-A1 ARYLOXYALKYLAMINE NK-1/SSRI INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-09 WO claimed
WO-2006014942-A1 ARYLOXYALKYLAMINE NK-1/SSRI INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-09 WO disclosed